UK MHRA Prepares To Roll-Out Decentralized Manufacturing Framework

New Guidelines Will Clarify Criteria To Enable Point Of Care And Modular Manufacturing

 
• By Vibha Sharma

The UK’s medicines regulator is pressing on with clarifying its expectations on decentralized manufacturing of medicines.

Gene Therapy for Cancer Treatment Concept Cancer therapy with T-cell and pipette
Decentralized manufacturing allows safe, personalized medicine production near patients (Shutterstock)

More from United Kingdom

More from Compliance